ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	22/151	191/7206	4.86932855572e-11
ko04380	Osteoclast differentiation	17/151	134/7206	2.02838140421e-09
ko05164	Influenza A	18/151	167/7206	9.40114119109e-09
ko04621	NOD-like receptor signaling pathway	17/151	157/7206	2.33145947014e-08
ko05162	Measles	15/151	120/7206	2.34545627902e-08
ko04610	Complement and coagulation cascades	12/151	79/7206	7.07925685157e-08
ko04620	Toll-like receptor signaling pathway	13/151	100/7206	1.32566068628e-07
ko04668	TNF signaling pathway	14/151	120/7206	1.70439311819e-07
ko04630	Jak-STAT signaling pathway	14/151	132/7206	5.61634903247e-07
ko05150	Staphylococcus aureus infection	8/151	36/7206	5.68303646588e-07
ko05131	Shigellosis	11/151	82/7206	9.26505542841e-07
ko05168	Herpes simplex infection	16/151	182/7206	1.10648537108e-06
ko05321	Inflammatory bowel disease (IBD)	9/151	56/7206	2.00656227257e-06
ko05160	Hepatitis C	14/151	153/7206	3.3623751677e-06
ko04064	NF-kappa B signaling pathway	11/151	96/7206	4.53675781474e-06
ko04622	RIG-I-like receptor signaling pathway	9/151	62/7206	4.82728719116e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	15/151	191/7206	9.86261911683e-06
ko05133	Pertussis	10/151	87/7206	1.21686073199e-05
ko05161	Hepatitis B	14/151	173/7206	1.40816670228e-05
ko04623	Cytosolic DNA-sensing pathway	7/151	41/7206	1.90900104651e-05
ko04210	Apoptosis	14/151	180/7206	2.20991285542e-05
ko05140	Leishmaniasis	9/151	75/7206	2.3700811721e-05
ko05132	Salmonella infection	10/151	98/7206	3.4982673991e-05
ko04062	Chemokine signaling pathway	14/151	201/7206	7.49787104213e-05
ko05142	Chagas disease (American trypanosomiasis)	11/151	130/7206	8.11781814882e-05
ko04672	Intestinal immune network for IgA production	6/151	37/7206	0.000104182914993
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/151	135/7206	0.000114275841235
ko05134	Legionellosis	8/151	74/7206	0.000144368929502
ko04660	T cell receptor signaling pathway	10/151	124/7206	0.000256026837859
ko05145	Toxoplasmosis	10/151	126/7206	0.00029167254944
ko05144	Malaria	6/151	45/7206	0.000317963510087
ko05340	Primary immunodeficiency	5/151	30/7206	0.000352902776809
ko04659	Th17 cell differentiation	9/151	106/7206	0.000356934181055
ko05323	Rheumatoid arthritis	8/151	89/7206	0.000519187016241
ko05152	Tuberculosis	12/151	187/7206	0.000527051729396
ko04658	Th1 and Th2 cell differentiation	8/151	96/7206	0.000861720928068
ko04666	Fc gamma R-mediated phagocytosis	9/151	122/7206	0.000998017491864
ko04217	Necroptosis	11/151	178/7206	0.00122768238295
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/151	182/7206	0.0014697622593
ko05212	Pancreatic cancer	7/151	83/7206	0.00169245194213
ko04662	B cell receptor signaling pathway	7/151	88/7206	0.00237245028958
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/151	92/7206	0.00305435672655
ko05169	Epstein-Barr virus infection	11/151	206/7206	0.00387846873893
ko04670	Leukocyte transendothelial migration	9/151	151/7206	0.00432142446078
ko05130	Pathogenic Escherichia coli infection	6/151	77/7206	0.00534829925945
ko04931	Insulin resistance	8/151	137/7206	0.00791568187942
ko04917	Prolactin signaling pathway	6/151	87/7206	0.00960918193982
ko05166	HTLV-I infection	13/151	292/7206	0.00989835111153
ko04920	Adipocytokine signaling pathway	6/151	89/7206	0.0106886779162
ko04650	Natural killer cell mediated cytotoxicity	6/151	97/7206	0.0158724562291
ko05100	Bacterial invasion of epithelial cells	6/151	99/7206	0.0174000352981
ko05219	Bladder cancer	4/151	48/7206	0.0176524689316
ko04611	Platelet activation	8/151	163/7206	0.020913122907
ko04612	Antigen processing and presentation	5/151	77/7206	0.0223305500846
ko04810	Regulation of actin cytoskeleton	11/151	264/7206	0.0258510490691
ko05220	Chronic myeloid leukemia	5/151	85/7206	0.0325002248279
ko04657	IL-17 signaling pathway	5/151	87/7206	0.0354285734958
ko00254	Aflatoxin biosynthesis	1/151	2/7206	0.0414732653005
ko00660	C5-Branched dibasic acid metabolism	1/151	2/7206	0.0414732653005